Cargando…

Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants

Non-O1, non-O139 Vibrio cholera (NOVC) are considered non-pathogenic organisms, but in some cases, it is known to be responsible for self-limiting intestinal and extra-intestinal infections in immunocompetent individuals. On the other hand, NOVC bacteremia affects mainly immunocompromised patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogari, Anas A, Alsolami, Basel M, Al-Husayni, Faisal, Munshi, Adeeb, Alharbi, Maher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712209/
https://www.ncbi.nlm.nih.gov/pubmed/34976485
http://dx.doi.org/10.7759/cureus.19853
_version_ 1784623518098391040
author Bogari, Anas A
Alsolami, Basel M
Al-Husayni, Faisal
Munshi, Adeeb
Alharbi, Maher
author_facet Bogari, Anas A
Alsolami, Basel M
Al-Husayni, Faisal
Munshi, Adeeb
Alharbi, Maher
author_sort Bogari, Anas A
collection PubMed
description Non-O1, non-O139 Vibrio cholera (NOVC) are considered non-pathogenic organisms, but in some cases, it is known to be responsible for self-limiting intestinal and extra-intestinal infections in immunocompetent individuals. On the other hand, NOVC bacteremia affects mainly immunocompromised patients with significantly high mortality rates. We report a case of an 80-year-old female with a 20-year history of multiple abdominal surgeries. She is also known to have ischemic heart disease and atrial fibrillation. The patient presented with abdominal pain and signs of septic shock. Her abdominal imaging showed features of ascending cholangitis, while her blood culture grew V. cholera. She was discharged after completing the course of antibiotics but then came back with a similar presentation. The repeated blood culture showed Clostridium perfringens, while other cultures were negative. The patient's condition worsened due to sepsis, and she passed away. NOVC bacteremia is a fatal disease even in hosts who are not receiving immunosuppressants or chemotherapy. It may present without a history of diarrhea or seafood ingestion. In such situations, abdominal imaging is necessary to identify the presence of intra-abdominal infections. 
format Online
Article
Text
id pubmed-8712209
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-87122092021-12-30 Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants Bogari, Anas A Alsolami, Basel M Al-Husayni, Faisal Munshi, Adeeb Alharbi, Maher Cureus Internal Medicine Non-O1, non-O139 Vibrio cholera (NOVC) are considered non-pathogenic organisms, but in some cases, it is known to be responsible for self-limiting intestinal and extra-intestinal infections in immunocompetent individuals. On the other hand, NOVC bacteremia affects mainly immunocompromised patients with significantly high mortality rates. We report a case of an 80-year-old female with a 20-year history of multiple abdominal surgeries. She is also known to have ischemic heart disease and atrial fibrillation. The patient presented with abdominal pain and signs of septic shock. Her abdominal imaging showed features of ascending cholangitis, while her blood culture grew V. cholera. She was discharged after completing the course of antibiotics but then came back with a similar presentation. The repeated blood culture showed Clostridium perfringens, while other cultures were negative. The patient's condition worsened due to sepsis, and she passed away. NOVC bacteremia is a fatal disease even in hosts who are not receiving immunosuppressants or chemotherapy. It may present without a history of diarrhea or seafood ingestion. In such situations, abdominal imaging is necessary to identify the presence of intra-abdominal infections.  Cureus 2021-11-24 /pmc/articles/PMC8712209/ /pubmed/34976485 http://dx.doi.org/10.7759/cureus.19853 Text en Copyright © 2021, Bogari et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Bogari, Anas A
Alsolami, Basel M
Al-Husayni, Faisal
Munshi, Adeeb
Alharbi, Maher
Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants
title Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants
title_full Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants
title_fullStr Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants
title_full_unstemmed Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants
title_short Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants
title_sort vibrio cholera bacteremia secondary to ascending cholangitis in a patient not on chemotherapy or immunosuppressants
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712209/
https://www.ncbi.nlm.nih.gov/pubmed/34976485
http://dx.doi.org/10.7759/cureus.19853
work_keys_str_mv AT bogarianasa vibriocholerabacteremiasecondarytoascendingcholangitisinapatientnotonchemotherapyorimmunosuppressants
AT alsolamibaselm vibriocholerabacteremiasecondarytoascendingcholangitisinapatientnotonchemotherapyorimmunosuppressants
AT alhusaynifaisal vibriocholerabacteremiasecondarytoascendingcholangitisinapatientnotonchemotherapyorimmunosuppressants
AT munshiadeeb vibriocholerabacteremiasecondarytoascendingcholangitisinapatientnotonchemotherapyorimmunosuppressants
AT alharbimaher vibriocholerabacteremiasecondarytoascendingcholangitisinapatientnotonchemotherapyorimmunosuppressants